Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals (Orchid Pharma), which is engaged in drug discovery in therapeutic segments, is planning to enter into out-licensing arrangements with multinational pharma companies (MNCs), after the successful completion of trials.
The company is in the process of transitioning its new chemical entities through various stages of pre-clinical and human clinical studies. These segments include diabetes, inflammation, cancer, auto immune disorders, anti infectives and obesity.
